MSD
The Director (Principal Scientist) leads clinical research for new and marketed medicines within the Metabolism section of the Atherosclerosis & Metabolism therapeutic area, focusing on obesity and related disorders. This role oversees the full lifecycle of late‑stage clinical studies, including design, execution, monitoring, analysis, regulatory reporting, and publication, while collaborating with cross‑functional teams and external investigators.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Executive Director (Distinguished Scientist)
Merck & Co., Inc.
Senior Director, Clinical Research, Atherosclerosis
Merck & Co., Inc.
Senior Director, Clinical Research, Atherosclerosis
Merck & Co., Inc.
Senior Director, Clinical Research, Atherosclerosis
Merck & Co., Inc.
Senior Director, Clinical Research, Atherosclerosis
Merck & Co., Inc.
Medical Director, Clinical Sciences, MASH/Metabolism (Regeneron Genetics Medicine)
Regeneron Pharmaceuticals